Keyword: GlaxoSmithKline

J&J and Allergan are among the pharma companies mulling both acquisitions and selloffs, signaling that the M&A boom will continue through 2018.

Two U.S. senators urged GlaxoSmithKline to do more about the ongoing shortage of Shingrix.

As the public plots protests, officials plan a black-tie dinner with the president and PM Theresa May—and J&J, GSK chiefs are invited.

Officials have vaccinated about 3,200 individuals in the Democratic Republic of Congo in response to a deadly outbreak.

GlaxoSmithKline's Shingrix is exceeding sales expectations, and high demand has led the company to implement order limits.

Here is some other vaccine news of note for the week.

Patients might be hesitant to return for their second Shingrix dose if they experience side effects, according to doctors.

Higher salary and more room for growth under an entrepreneurial environment are driving Chinese global pharma executives to domestic biotechs.

Shiny statuettes and heart-tugging creative were the rule of the day as we followed pharma marketers and agency leaders into awards night.

Thought Mylan might snag a generic Advair approval on its second try? Think again.